none taken kates. gd to see u on here and appreciate ur ta on this amongst others.
like you mentioned, you really have to be holding shares before ann are out. a licensing agreement will easily double the sp within a day for micro-cap pharma coy.
from e exchange of emails as well as previous ann from coy, i do expect more license agreements with big names by years end and Dr Cummings doesnt rule out one before the AGM.
southern cross equities recommends a spec buy in their report; valuing Anteo at $0.13 per share base case and $0.24 optimistic case using a high-discount-rate (ie 25%) DCF valuation. their target price of $0.13 sits at their base case valuation. they see potential for a rerating of Anteo as further licensing deals emerge and early revenue is generated from Bangs and Merck.
- Forums
- ASX - By Stock
- fin rev article
none taken kates. gd to see u on here and appreciate ur ta on...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $46.90M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $23.42K | 1.233M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1142321 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 339684 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1142321 | 0.019 |
10 | 1338162 | 0.018 |
5 | 807891 | 0.017 |
5 | 1629529 | 0.016 |
7 | 1203869 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 339684 | 2 |
0.021 | 592746 | 5 |
0.022 | 505000 | 2 |
0.023 | 420000 | 2 |
0.024 | 164509 | 3 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |